Somewhere along the way, maybe in March 2020, there must have been a big meeting with all the heads of the pharmaceutical companies and their scientists. They were all scratching their heads, wondering, how do we defeat this virus? And it must have been all, because they ALL came to the same conclusion. Maybe it was that at the meeting some intern at the back piped up: what about attacking that spike? Yes! THE SPIKE! The scientists roared in approval. And so they set out to attack the spike and leave the rest of the virus alone.
The more I think about it, the more ludicrous the idea of attacking the spike sounds. And isn’t it amazing how quickly they were able to notice the spike, isolate the spike, and engineer mechanisms for its creation inside human cells? What did it take, 3 or 4 months before human trials began? It’s almost as though they had the spike from the beginning. And they were just waiting for the right virus.
Am I imagining things?
2020
“You may be surprised to learn that of the trio of long-awaited coronavirus vaccines, the most promising, Moderna’s mRNA-1273, which reported a 94.5 percent efficacy rate on November 16, had been designed by January 13. This was just two days after the genetic sequence had been made public in an act of scientific and humanitarian generosity that resulted in China's Yong-Zhen Zhang’s being temporarily forced out of his lab. In Massachusetts, the Moderna vaccine design took all of one weekend. It was completed before China had even acknowledged that the disease could be transmitted from human to human, more than a week before the first confirmed coronavirus case in the United States. By the time the first American death was announced a month later, the vaccine had already been manufactured and shipped to the National Institutes of Health for the beginning of its Phase I clinical trial. This is — as the country and the world are rightly celebrating — the fastest timeline of development in the history of vaccines...”
https://nymag.com/intelligencer/2020/12/moderna-covid-19-vaccine-design.html